Pnc Financial Services Group, Inc. Collegium Pharmaceutical, Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 575 shares of COLL stock, worth $16,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
575
Previous 912
36.95%
Holding current value
$16,370
Previous $35,000
54.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$165 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$75.1 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$66.9 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$65 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$61 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $972M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...